Elevation Oncology downgraded as it halts lead asset on disappointing trials [Yahoo! Finance]
Piper Sandler Companies (PIPR)
Last piper sandler companies earnings: 5/1 08:04 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Analysts now see limited near-term catalysts, with Elevation pivoting to its HER3-targeted ADC, EO-1022, which is still in preclinical development. Piper Sandler downgraded Elevation to “Neutral” from “Overweight” and slashed its price target to $0.70 from prior levels, citing the company's decision to halt EO-3021's development and focus on EO-1022. While EO-3021 demonstrated differentiated safety, its 22% ORR in monotherapy dose escalation was not enough to justify further development, according to Piper . The firm's new price target reflects projected cash on hand at year-end 2025, with limited upside potential until EO-1022 progresses further. Citizens also moved its rating to “Market Perform” from “Market Outperform,” citing the lack o
Read more
Impact Snapshot
Event Time:
PIPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PIPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PIPR alerts
High impacting Piper Sandler Companies news events
Weekly update
A roundup of the hottest topics
PIPR
News
- Rivian Stock Drops After Downgrade. ‘It Pains Us,' Analyst Says. [Yahoo! Finance]Yahoo! Finance
- Analyst on Intel (INTC): New CEO Appointment ‘Very Smart Move' Despite ‘No AI Pipeline' [Yahoo! Finance]Yahoo! Finance
- Tela Bio slumps after Q4 miss as Piper Sandler downgrades [Seeking Alpha]Seeking Alpha
- Gen Z boys are turning to fragrance as a form of expression and self care [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why investors shouldn't be looking for 'home runs' right now [Yahoo! Finance]Yahoo! Finance
PIPR
Earnings
- 1/31/25 - Beat
PIPR
Sec Filings
- 3/24/25 - Form ARS
- 3/17/25 - Form 4
- 3/17/25 - Form 4
- PIPR's page on the SEC website